MarginsXMarginsX
Home › Markets › Health Care › GRAL

GRAIL Inc. Common Stock (GRAL)

GRAL trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$105.60
-8.88% on the day
Market cap
$4.7B
Mid cap
Revenue · 2025
$147.2M
+17.2% on 2024
Net income · 2025
-$408.4M
-277.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1699031/000162828026017319/0001628280-26-017319-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerGRAL on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001699031
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$147.2M
Net income-$408.4M
Operating income-$562.2M
Net margin-277.5%
Operating margin-382.0%
Revenue growth+17.2%
Cash$249.7M
Total assets$2.9B
P/E (computed)Net income was not positive
P/S (computed)32.3×

Warning signs

Cash runway
1.1 months
$29.0M cash at September 30, 2026
Share count, 1 year
+15.3%
2025-11-10 to 2026-11-02
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$118.0M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$29.0M cash; operating cash flow -$76.6M a quarter.Report 2026-09-30
Shares outstanding44,962,171 (2026-11-02); 38,982,223 a year earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Mateo, California, United StatesPCAOB Form AP 2026-03-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $118.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$37.5M-$103.6M-$74.7M$29.0MNo debt tags$166.6M10-Q 2026-11-05
Q2 2026
2026-06-30
$44.7M-$110.2M-$80.7M$55.6MNo debt tags$165.3M10-Q 2026-08-06
Q1 2026
2026-03-31
$40.8M-$93.2M-$87.0M$69.3MNo debt tags$156.1M10-Q 2026-05-07
Q4 2025
2025-12-31
$43.6M-$99.2M-$63.8M$249.7MNo debt tags$147.2M10-K 2026-03-12
Q3 2025
2025-09-30
$36.2M-$89.0M-$63.2M$126.9MNo debt tags$141.8M10-Q 2026-11-05
Q2 2025
2025-06-30
$35.5M-$114.0M-$77.0M$127.4MNo debt tags$134.3M10-Q 2026-08-06
Q1 2025
2025-03-31
$31.8M-$106.2M-$95.0M$133.9MNo debt tags$130.7M10-Q 2026-05-07
Q4 2024
2024-12-31
$38.3M-$97.1M-$93.5M$214.2MNo debt tags$125.6M10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-11-14
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 268 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.6%
1 month-17.4%
3 months+69.8%
Year to date+35.4%
1 year+39.3%
From 52-week high-27.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
BLLNBillionToOne Inc.$96.31-8.41%$4.6B
CONConcentra Group Holdings Parent Inc.$43.44+2.09%$5.5B
CDNACareDx Inc.$73.72-5.34%$3.9B
CAICaris Life Sciences Inc.$21.00-8.85%$6.0B
RDNTRadNet Inc.$76.89+0.61%$6.1B
ACHCAcadia Healthcare Company Inc.$38.70+2.44%$3.6B
CELCCelcuity Inc.$60.57-5.90%$3.0B
CLOVClover Health Investments Corp.$4.95-0.20%$2.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier